Tablet for gastric ulcer
Fliban(Flibanserin) , sold under the trade name Addyi, is a medication approved for the treatment of pre-menopausal women with hypoactive desire disorder .
Flibanserin is used for hypoactive desire disorder among women. Those receiving flibanserin report that the average number of times they had “satisfying events” rose from 2.8 to 4.5 times a month. However, women receiving placebo reported also an increase of “satisfying events” from 2.7 to 3.7 times a month. Evaluation of the overall improvement of their condition and whether the benefit was meaningful to the women, showed a significantly higher rate of a meaningful benefit in the flibanserin-treated people versus the placebo group. The onset of the flibanserin effect was seen from the first timepoint measured after 4 weeks of treatment and maintained throughout the treatment period.